Immunogenicity of SARS-CoV-2 vaccines in patients treated with chronic double filtration plasmapheresis.

Emilie PambrunPaul LoubetThomas FourneronOlivier Moranne

Published in: Journal of clinical apheresis (2024)

Humoral response to SARS-CoV-2 vaccination appears robust in patients undergoing chronic DFPP and may be linked to patients' immune status rather than DFPTP itself. Our results support current recommendations for administering three doses of vaccine with a booster every 6 months.

Keyphrases

sars cov
patients undergoing
end stage renal disease
respiratory syndrome coronavirus
immune response
newly diagnosed
ejection fraction
peritoneal dialysis
patient reported outcomes
drug induced
patient reported